Approval · Notice of Compliance 2240 · 2001
ZARONTIN: Notice of Compliance 2240
Issued January 11, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2240
- Date
- January 11, 2001
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anticonvulsant
Products in this notice
Medicinal ingredients
- ETHOSUXIMIDE 250 MG per 5ML
- ETHOSUXIMIDE 250 MG per CAP